Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on D Threonine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114703169A reveals a novel L-threonine aldolase mutant for Droxidopa. Achieves 92.89% selectivity. Ideal for pharma intermediates supply.
Patent CN116813659A introduces a threonine-based chiral catalyst enabling high enantioselectivity and cost-effective manufacturing for complex pharmaceutical intermediates.
Patent CN1884284A details a high-yield Faropenem Sodium process using L-Threonine. Discover cost-effective API intermediate manufacturing and supply chain advantages.
Patent CN113773214A reveals a scalable four-step route for N-methyl-D-threonine, eliminating chromatography for significant cost reduction in pharmaceutical manufacturing.